key: cord-1031808-r4n7q6tk
authors: Wee, Liang En; Conceicao, Edwin Philip; Sim, Jean Xiang-Ying; Aung, May Kyawt; Venkatachalam, Indumathi
title: The impact of visitor restrictions on healthcare-associated respiratory viral infections during the COVID-19 pandemic: experience of a tertiary hospital in Singapore
date: 2020-11-10
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2020.11.006
sha: 1eaf0881a07510609b9c1e145b6d4970ceb37a56
doc_id: 1031808
cord_uid: r4n7q6tk

nan

We read with interest the recent article by Weiner et al. that described hospital visitation policies during the coronavirus disease 2019 (COVID-19) pandemic and called for epidemiological evidence to support and inform the imposition of visitor restrictions. 1 Indeed, the imposition of visitor restrictions has been introduced in various healthcare settings to mitigate transmission of SARS-CoV-2; 2,3 however, as such measures were typically imposed as part of a bundle of other infection-prevention measures, the actual contribution of visitor restrictions in minimizing healthcare-associated transmission of respiratory-viralinfections (RVIs) is unclear. Furthermore, evidence is emerging that restricting access to family caregivers and visitors poses risks of social isolation, psychological distress, and delayed recovery, 4 which has to be weighed against potential benefits associated with preventing healthcare-associated RVIs (HA-RVI).

In Singapore, a Southeast Asian city-state, various infection-prevention measures were implemented soon after the first reported case of COVID-19 in end-January 2020. From February 2020 onwards, a COVID-19 containment strategy was implemented across the largest healthcare campus in Singapore, comprising the Singapore General Hospital (SGH), the largest acute tertiary hospital in Singapore (1735 beds); a 545-bed community hospital as well as four subspecialty centres in cardiology, neurology, ophthalmology and oncology, all located on a single site (Figure 1a ). Our institution's campus-wide approach involved improved segregation of patients with respiratory symptoms, universal masking of staff, patients and visitors, point-ofentry temperature screening for all staff and visitors, as well as visitor limitations/visitor restrictions. 3 All visitors underwent mandatory screening upon entry; visitors with fever, respiratory symptoms or significant travel/epidemiological history would be denied entry (Figure 1b) . Prior to the pandemic, a visitor limit of four visitors was in-place; from February 2020 onwards, only one visitor was allowed. In April-May 2020, visitor restrictions were instituted and no visitors were allowed. From June 2020 onwards, hospitalized inpatients were allowed a single visitor; finally, from August 2020 onwards, visitor limits were relaxed to two visitors (Figure 1c) . The combined infection-prevention bundle was remarkably successful in mitigating healthcare-associated transmission of SARS-CoV-2, with no patient/visitor-HCW transmission. 3 As an unintended positive consequence, a substantial decrease in HA-RVI was detected soon after introduction of the infection-prevention bundle, though simultaneous introduction made it difficult to ascertain the specific contribution of visitor restriction. 5 However, given that visitor restrictions were relaxed progressively while all other infection-prevention measures were maintained, it was possible to evaluate if the relaxation of visitor restrictions coincided with a subsequent rebound in HA-RVI.

Over an eight-month study period from February 2020-September 2020, all symptomatic inpatients campuswide were tested for COVID-19 and 16 common RVIs, including influenza, via multiplex PCR. Cases of RVI were categorized as HA-RVI if the RVI was identified beyond the maximum incubation period from the time of admission. 5 Comparisons of HA-RVI rates during the pandemic period were compared with the prepandemic period (January 2018-January 2020) using the incidence-rate-ratio method, with the null hypothesis being that the incidence of HA-RVI would be proportional to the number of inpatient days at-risk for each period. Trends in HA-RVI were then correlated against the sequential imposition and relaxation of visitor restrictions/limits. The institutional review board of SGH approved the study and waived informed consent.

Prior to the COVID-19 outbreak, the campus-wide cumulative incidence of HA-RVI was 9.69 cases per-10,000 patient-days (989 cases; 1,020,463 patient-days). After visitor limitations (single-visitor policy) were introduced together with other infection prevention measures in February 2020, the cumulative incidence of PCR-proven HA-RVI fell to 2.23 cases per-10,000 patient-days (15 cases; 67,335 patient-days), a statistically significant decrease (incidence-rate-ratio, IRR=0.23, 95%CI=0.13-0.38, p<0.001) (Figure 1a) . From April-May 2020, after the imposition of visitor restrictions (no-visitors policy), the cumulative incidence of HA-RVI fell further to 0.66 cases per-10,000 patient-days (5 cases; 75,203 patient-days; IRR=0.30, 95%CI=0.08-0.86, p=0.013). From June-July 2020, after the rollback of visitor restrictions (single-visitor policy), the cumulative incidence of HA-RVI remained low, at 0.24 cases per-10,000 patient-days (2 cases; 81,866 patient-days); there was no statistically significant difference in HA-RVI compared with the preceding two months when visitor restrictions were enforced (IRR=0.36, 95%CI=0.03-2.24, p=0.212). Finally, from August-September 2020, after the further relaxation of visitor limitations (two-visitor policy), the cumulative incidence of HA-RVI remained at 0.12 cases per-10,000 patient-days (1 case; 80,602 patient-days); further relaxation of visitor limitations did not coincide with a significant increase in HA-RVI (IRR=0.57, 95%CI=0.01-9.76, p=0.573).

Over the study period, despite managing ≥1600 cases of COVID-19, only one case of potential healthcareassociated transmission was detected. 3 The key finding of this study is that while visitor restrictions introduced as part of an infection-prevention bundle initially coincided with a significant and substantial drop in healthcare-associated transmission of common RVIs across a large healthcare campus, the subsequent rollback of visitor restrictions and visitor limitations was not associated with a subsequent rebound in HA-RVI. Visitor management complements other infection prevention efforts and needs to be calibrated carefully taking into consideration patients' psychological well-being and prevention of infection transmission.

Hospital Visitation Policies During the SARS-CoV-2

Hospital visiting policies in the time of coronavirus disease 2019: A nationwide website survey in Taiwan

Containing COVID-19 outside the isolation ward: the impact of an infection control bundle on environmental contamination and transmission in a cohorted general ward

Impact of visitor restriction rules on the postoperative experience of COVID-19 negative patients undergoing surgery

Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak

The authors report no conflicts of interest. This work was not grant-funded.Word count: 800 words